Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
ANZ Journal of Surgery|January 18, 2008
Gastrin is not required for liver regenerationAmra Dizdarevic, Nadia Harun, Cathy Malcontenti-Wilson, et al.Cancer Science|June 29, 2010
In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastasesJurstine Daruwalla, Mehrdad Nikfarjam, Khaled Greish, et al.Journal of Vascular Research|October 28, 2008
Styrene maleic acid-pirarubicin disrupts tumor microcirculation and enhances the permeability of colorectal liver metastasesJurstine Daruwalla, Khaled Greish, Cathy Malcontenti-Wilson, et al.Journal of Drug Targeting|August 3, 2007
Evaluation of the effect of SMA-pirarubicin micelles on colorectal cancer liver metastases and of hyperbaric oxygen in CBA miceJurstine Daruwalla, Khaled Greish, Mehrdad Nikfarjam, et al.Cancer Letters|November 22, 2011
P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growthHong He, Nhi Huynh, Kevin H Liu, et al.Cancer Medicine|January 10, 2014
Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumorTheodora Fifis, Linh Nguyen, Cathy Malcontenti-Wilson, et al.The Journal of Pharmacology and Experimental Therapeutics|September 16, 2011
The microtubule depolymerizing agent CYT997 causes extensive ablation of tumor vasculature in vivoChristopher J Burns, Emmanuelle Fantino, Andrew K Powell, et al.Molecular Cancer Therapeutics|November 6, 2009
CYT997: a novel orally active tubulin polymerization inhibitor with potent cytotoxic and vascular disrupting activity in vitro and in vivoChristopher J Burns, Emmanuelle Fantino, Ian D Phillips, et al.Pageof 2